<DOC>
	<DOCNO>NCT00003251</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use x-rays damage tumor cell . Drugs , amifostine , may protect normal cell side effect chemotherapy radiation therapy . PURPOSE : Phase I/II trial study effectiveness amifostine plus cisplatin , paclitaxel , radiation therapy treat patient advance unresectable head neck cancer .</brief_summary>
	<brief_title>Amifostine Plus Chemotherapy Radiation Therapy Treating Patients With Advanced , Unresectable Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : I. Assess efficacy role amifostine cytoprotection agent concurrent chemoradiotherapy advance , previously irradiate metastatic head neck cancer . II . Determine toxicity response cisplatin , paclitaxel radiation therapy patient . III . Determine toxicity amifostine patient . OUTLINE : This open label study . Patients receive paclitaxel continuous infusion day 0-3 . Amifostine IV administer 5 minute day 1-5 . Radiation therapy administer daily day 1-5 . Cisplatin IV administer day 5 . Patients receive treatment day 6-13 . Treatment repeat every 2 week 7 course absence disease progression unacceptable toxicity . Patients follow monthly first year , every 2 month second year , every 3 month thereafter . PROJECTED ACCRUAL : This study accrue 16-46 patient .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Amifostine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically document metastatic previously irradiate recurrent locoregional squamous cell mucoepidermoid carcinoma head neck Unresectable disease PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 OR Karnofsky 70100 % Life expectancy : Greater 4 month Hematopoietic : WBC least 3000/mm3 Platelet count least 100,000/mm3 Granulocyte count least 1500/mm3 Hepatic : Bilirubin great 2.5 time normal SGOT SGPT great 2.5 time upper limit normal Renal : Creatinine great 1.5 mg/dL Creatinine clearance least 60 mL/min Other : No significant infection No medical psychiatric illness Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 1 month since prior chemotherapy Endocrine therapy : Not specify Radiotherapy : At least 3 month since prior radiotherapy ( patient recurrent disease ) head neck region Surgery : Not speciified Other : At least 24 hour since antihypertensive medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2000</verification_date>
	<keyword>stage III nasopharyngeal cancer</keyword>
	<keyword>stage IV nasopharyngeal cancer</keyword>
	<keyword>recurrent nasopharyngeal cancer</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>salivary gland squamous cell carcinoma</keyword>
	<keyword>high-grade salivary gland mucoepidermoid carcinoma</keyword>
	<keyword>stage III lip oral cavity cancer</keyword>
	<keyword>stage IV lip oral cavity cancer</keyword>
	<keyword>recurrent lip oral cavity cancer</keyword>
	<keyword>stage III hypopharyngeal cancer</keyword>
	<keyword>stage IV hypopharyngeal cancer</keyword>
	<keyword>recurrent hypopharyngeal cancer</keyword>
	<keyword>stage III laryngeal cancer</keyword>
	<keyword>stage IV laryngeal cancer</keyword>
	<keyword>recurrent laryngeal cancer</keyword>
	<keyword>stage III paranasal sinus nasal cavity cancer</keyword>
	<keyword>stage IV paranasal sinus nasal cavity cancer</keyword>
	<keyword>recurrent paranasal sinus nasal cavity cancer</keyword>
	<keyword>stage III oropharyngeal cancer</keyword>
	<keyword>stage IV oropharyngeal cancer</keyword>
	<keyword>recurrent oropharyngeal cancer</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>drug/agent toxicity tissue/organ</keyword>
	<keyword>radiation toxicity</keyword>
</DOC>